The overexpression of MERTK resulted in the activation of pathways that prevent cell death, leading to lymphoblastic leukemia/lymphoma in 60% of the MERTK transgenic mice, with hematopoietic expression driven by VAV promoter [43]. Here, MERTK is linked to lymphoma.